Article info

Download PDFPDF
Adverse events to PCSK-9 inhibitors: what is the current evidence?

Authors

  1. Correspondence to Martin Crook, Clinical Biochemistry, Guy’s Hospital, Clinical Biochemistry, London SE1 9RT, UK; Martin.crook{at}doctors.org.uk
View Full Text

Citation

Floyd C, Crook M
Adverse events to PCSK-9 inhibitors: what is the current evidence?

Publication history

  • Received July 22, 2020
  • Revised August 5, 2020
  • Accepted August 6, 2020
  • First published September 15, 2020.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.